A Study of MK-8527 in Healthy Adult Participants (MK-8527-013)
NCT06826989
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
[14C]MK-8527
Sponsor
Merck Sharp & Dohme LLC